Idioma:

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Meador, Kimford J, Prof ; Baker, Gus A, PhD ; Browning, Nancy, PhD ; Cohen, Morris J, EdD ; Bromley, Rebecca L, PhD ; Clayton-Smith, Jill, MD ; Kalayjian, Laura A, MD ; Kanner, Andres, MD ; Liporace, Joyce D, MD ; Pennell, Page B, MD ; Privitera, Michael, MD ; Loring, David W, PhD

Lancet neurology, 2013-03, Vol.12 (3), p.244-252 [Revista revisada por pares]

England: Elsevier Ltd

Texto completo disponible

Citas Citado por

Acciones

Título:
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study
Autor: Meador, Kimford J, Prof ; Baker, Gus A, PhD ; Browning, Nancy, PhD ; Cohen, Morris J, EdD ; Bromley, Rebecca L, PhD ; Clayton-Smith, Jill, MD ; Kalayjian, Laura A, MD ; Kanner, Andres, MD ; Liporace, Joyce D, MD ; Pennell, Page B, MD ; Privitera, Michael, MD ; Loring, David W, PhD
Materias: Adult ; Age ; Anticonvulsants - adverse effects ; Anticonvulsants - therapeutic use ; Antiepileptic agents ; Birth weight ; Breastfeeding & lactation ; Carbamazepine ; Child ; Child Development - drug effects ; Child, Preschool ; Children ; Cognition - drug effects ; Cognitive ability ; Compliance ; Convulsions & seizures ; Drug dosages ; Drug use ; Employment ; Epilepsy ; Epilepsy - drug therapy ; Epilepsy - psychology ; FDA approval ; Female ; Fetuses ; Folic acid ; Humans ; Infant ; Infant, Newborn ; Intelligence ; lamotrigine ; Male ; Minority & ethnic groups ; Missing data ; Neurology ; Neuropsychology ; Observation - methods ; Parent educational background ; Phenytoin ; Phenytoin - adverse effects ; Phenytoin - therapeutic use ; Pregnancy ; Pregnancy Complications - drug therapy ; Prenatal Exposure Delayed Effects - chemically induced ; Prenatal Exposure Delayed Effects - physiopathology ; Prospective Studies ; Socioeconomic factors ; Triazines - adverse effects ; Triazines - therapeutic use ; Valproic acid ; Vitamin B ; Womens health
Es parte de: Lancet neurology, 2013-03, Vol.12 (3), p.244-252
Notas: ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
Descripción: Summary Background Many women of childbearing potential take antiepileptic drugs, but the cognitive effects of fetal exposure are uncertain. We aimed to assess effects of commonly used antiepileptic drugs on cognitive outcomes in children up to 6 years of age. Methods In this prospective, observational, assessor-masked, multicentre study, we enrolled pregnant women with epilepsy on antiepileptic drug monotherapy (carbamazepine, lamotrigine, phenytoin, or valproate) between October, 1999, and February, 2004, at 25 epilepsy centres in the UK and the USA. Our primary outcome was intelligence quotient (IQ) at 6 years of age (age-6 IQ) in all children, assessed with linear regression adjusted for maternal IQ, antiepileptic drug type, standardised dose, gestational birth age, and use of periconceptional folate. We also assessed multiple cognitive domains and compared findings with outcomes at younger ages. This study is registered with ClinicalTrials.gov , number NCT00021866. Findings We included 305 mothers and 311 children (six twin pairs) in the primary analysis. 224 children completed 6 years of follow-up (6-year-completer sample). Multivariate analysis of all children showed that age-6 IQ was lower after exposure to valproate (mean 97, 95% CI 94–101) than to carbamazepine (105, 102–108; p=0·0015), lamotrigine (108, 105–110; p=0·0003), or phenytoin (108, 104–112; p=0·0006). Children exposed to valproate did poorly on measures of verbal and memory abilities compared with those exposed to the other antiepileptic drugs and on non-verbal and executive functions compared with lamotrigine (but not carbamazepine or phenytoin). High doses of valproate were negatively associated with IQ ( r =–0·56, p<0·0001), verbal ability ( r =–0·40, p=0·0045), non-verbal ability ( r =–0·42, p=0·0028), memory ( r =–0·30, p=0·0434), and executive function ( r =–0·42, p=0·0004), but other antiepileptic drugs were not. Age-6 IQ correlated with IQs at younger ages, and IQ improved with age for infants exposed to any antiepileptic drug. Compared with a normative sample (173 [93%] of 187 children), right-handedness was less frequent in children in our study overall (185 [86%] of 215; p=0·0404) and in the lamotrigine (59 [83%] of 71; p=0·0287) and valproate (38 [79%] of 40; p=0·0089) groups. Verbal abilities were worse than non-verbal abilities in children in our study overall and in the lamotrigine and valproate groups. Mean IQs were higher in children exposed to periconceptional folate (108, 95% CI 106–111) than they were in unexposed children (101, 98–104; p=0·0009). Interpretation Fetal valproate exposure has dose-dependent associations with reduced cognitive abilities across a range of domains at 6 years of age. Reduced right-handedness and verbal ( vs non-verbal) abilities might be attributable to changes in cerebral lateralisation induced by exposure to antiepileptic drugs. The positive association of periconceptional folate with IQ is consistent with other recent studies. Funding US National Institutes of Health, UK Epilepsy Research Foundation.
Editor: England: Elsevier Ltd
Idioma: Inglés

Enlaces

View this record in MEDLINE/PubMed

Volver a la lista de resultados

Anterior Resultado 9 Siguiente Ir a la siguiente página

Realización: Logos de Redes Sociales:

Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study

Meador, Kimford J, Prof ; Baker, Gus A, PhD ; Browning, Nancy, PhD ; Cohen, Morris J, EdD ; Bromley, Rebecca L, PhD ; Clayton-Smith, Jill, MD ; Kalayjian, Laura A, MD ; Kanner, Andres, MD ; Liporace, Joyce D, MD ; Pennell, Page B, MD ; Privitera, Michael, MD ; Loring, David W, PhD

England: Elsevier Ltd

Buscando en bases de datos remotas, por favor espere